Cimerli (ranibizumab-eqrn) is used to treat
macular degeneration. Cimerli is a biosimilar for
lucentis (ranibizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Cimerli may be covered by your Medicare or insurance plan.